Formula: | C17H19N5 |
Molecular Weight: | 293.37 |
Rotatable Bond Donors: | 3 |
clogP: | 2.56 |
Topological Polar Surface Area: | 54.25 |
Lipinski's RO5: | MW: 293.37 HBA: 5 HBD: 2 RB: 3 LogP: 2.56 |
Rule of Three: | MW: 293.37 HBA: 5 HBD: 2 RB: 3 LogP: 2.56 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC29045411 | 1.0 | ZINC29045411 RDKit 3D 22 25 0 0 0 0 0 0 0 0999 V2000 1.1188 -2.2883 0.9811 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8800 -1.2440 0.4728 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2492 -0.1058 -0.0205 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9585 0.9744 -0.5431 N 0 0 0 0 0 0 0 0 0 0 0 0 3.4048 0.9773 -0.6046 C 0 0 0 0 0 0 0 0 0 0 0 0 4.0526 0.9857 0.7593 C 0 0 0 0 0 0 0 0 0 0 0 0 5.5593 0.9598 0.6161 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9648 -0.1933 -0.1766 N 0 0 0 0 0 0 0 0 0 0 0 0 5.4699 -0.0226 -1.5362 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9568 -0.0664 -1.5457 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1014 -0.0034 -0.0112 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.8323 -1.0260 0.4860 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2768 -0.8571 0.4690 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2606 -1.7261 0.9065 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.5187 -1.2218 0.7286 N 0 0 0 0 0 0 0 0 0 0 0 0 -4.3360 -0.0405 0.1818 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.2712 0.9505 -0.2317 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.8313 2.0994 -0.7744 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.4161 2.3615 -0.9529 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5261 1.4327 -0.5659 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9815 0.2383 -0.0017 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.2624 -2.1845 0.9911 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 2 3 1 0 3 4 1 0 4 5 1 0 5 6 1 0 6 7 1 0 7 8 1 0 8 9 1 0 9 10 1 0 3 11 2 0 11 12 1 0 12 13 1 0 13 14 2 0 14 15 1 0 15 16 2 0 16 17 1 0 17 18 2 0 18 19 1 0 19 20 2 0 20 21 1 0 12 22 2 0 22 1 1 0 10 5 1 0 21 13 1 0 21 16 1 0 M END $$$$ | ||
ZINC585263232 | 0.72 | ZINC585263232 RDKit 3D 22 25 0 0 0 0 0 0 0 0999 V2000 0.3079 0.3919 3.6924 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2001 1.1800 2.9783 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9846 1.3342 1.6176 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9222 2.1904 0.8290 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8182 1.3399 -0.0416 C 0 0 0 0 0 0 0 0 0 0 0 0 2.2541 1.2412 -1.4467 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2969 1.5096 -2.5138 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5144 0.7554 -2.2614 N 0 0 0 0 0 0 0 0 0 0 0 0 5.1193 1.1190 -0.9873 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2213 1.9048 -0.0502 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0531 0.7654 0.9566 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.9047 -0.0011 1.6743 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.0044 -0.6073 0.9416 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.0556 -1.3689 1.4203 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9028 -1.7715 0.4256 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.3913 -1.2730 -0.6779 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.8280 -1.3584 -2.0305 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.1181 -0.7568 -3.0011 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.9069 -0.0149 -2.7073 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4880 0.0729 -1.4340 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2255 -0.5506 -0.4241 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.7608 -0.2105 3.0400 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 2 3 1 0 3 4 1 0 4 5 1 0 5 6 1 0 6 7 1 0 7 8 1 0 8 9 1 0 9 10 1 0 3 11 2 0 11 12 1 0 12 13 1 0 13 14 2 0 14 15 1 0 15 16 2 0 16 17 1 0 17 18 2 0 18 19 1 0 19 20 2 0 20 21 1 0 12 22 2 0 22 1 1 0 10 5 1 0 21 13 1 0 21 16 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |